拥有逾 20 年行业经验：从实验室非临床病理学起步，逐步拓展至质量管理、安全管理及法规事务领域。经验覆盖 ATMPs（先进治疗药物产品）至消费医疗领域，服务对象从初创生物科技企业到大型制药巨头，担任高级管理、领导及咨询职位。Until recently working at the forefront of microbiome science, exploring immuno-oncological, neurodegenerative CNS and gastrointestinal indications. Now working on orphan drug development in the EU and US, as well as a number of clinical programmes in support of similar developments.